Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00034775
What this trial is testing

Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.

Who this might be right for
SchizophreniaPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 141
Post-approval studies (Phase 4)Study completedNCT00224822
What this trial is testing

The Effects of Aripiprazole on Patients With Metabolic Syndrome

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+1 more
New Mexico VA Healthcare System 27
Not applicableStudy completedNCT00538642
What this trial is testing

Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder
The University of Texas Health Science Center at San Antonio 24
Not applicableStudy completedNCT01160679
What this trial is testing

Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 231
Post-approval studies (Phase 4)Ended earlyNCT00649220
What this trial is testing

Memantine and Antipsychotics Use

Who this might be right for
Alzheimer's Disease
Merz Pharmaceuticals GmbH 19
Large-scale testing (Phase 3)UnknownNCT03284294
What this trial is testing

Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia

Who this might be right for
Schizophrenia
Universitas Padjadjaran 40
Large-scale testing (Phase 3)Looking for participantsNCT06961968
What this trial is testing

Randomized Withdrawal Study in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Vanda Pharmaceuticals 400
Not applicableUnknownNCT03192631
What this trial is testing

Financial Incentives to Improve Acceptance of Antipsychotic Injections

Who this might be right for
SchizophreniaSchizo Affective DisorderBipolar I Disorder
Focus Community Mental Health Team 20
Not applicableUnknownNCT02205437
What this trial is testing

Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia

Who this might be right for
Schizophrenia
Fundación Marques de Valdecilla 200
Post-approval studies (Phase 4)Looking for participantsNCT07483294
What this trial is testing

Cerebellum-based Imaging Neural Markers for Antipsychotic Response

Who this might be right for
Psychosis; Acute
Northwell Health 120
Post-approval studies (Phase 4)UnknownNCT00182494
What this trial is testing

Diabetes Prevention Program in Schizophrenia [DPPS]

Who this might be right for
Diabetes MellitusSchizophrenia
Hamilton Health Sciences Corporation 200
Not applicableStudy completedNCT01384279
What this trial is testing

The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced Obesity

Who this might be right for
Obesity
Beitou Armed Forces Hospital, Taipei, Taiwan 25
Large-scale testing (Phase 3)Study completedNCT02634346
What this trial is testing

ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)

Who this might be right for
Schizophrenia
Alkermes, Inc. 403
Post-approval studies (Phase 4)UnknownNCT03090503
What this trial is testing

Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up

Who this might be right for
SchizophreniaPsychotic DisordersPsychosis
Fundación Marques de Valdecilla 200
Not applicableActive Not RecruitingNCT05333003
What this trial is testing

Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity

Who this might be right for
Schizophrenia Spectrum Disorders
Centre for Addiction and Mental Health 92
Testing effectiveness (Phase 2)Study completedNCT00206570
What this trial is testing

Clinical Estradiol Trial in Women With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Bayside Health 100
Large-scale testing (Phase 3)Study completedNCT00419146
What this trial is testing

Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder+1 more
University Hospital, Aker 99
Testing effectiveness (Phase 2)Study completedNCT01176721
What this trial is testing

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
cerbomed GmbH 20
Not applicableStudy completedNCT00088751
What this trial is testing

Treatment Study of Frontotemporal Dementia

Who this might be right for
Frontotemporal Lobar Degeneration
National Institute of Neurological Disorders and Stroke (NINDS) 20
Not applicableStudy completedNCT00749970
What this trial is testing

Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
AstraZeneca 100
Next Page